A double-blind evaluation of 'Hydergine' and placebo in the treatment of patients with organic brain syndrome and cerebral arteriosclerosis in a nursing home.
- 1 January 1974
- journal article
- clinical trial
- Published by Informa Healthcare in Current Medical Research and Opinion
- Vol. 2 (8)
- https://doi.org/10.1185/03007997409115247
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- A New Scale for Clinical Assessment in Geriatric Populations: Sandoz Clinical Assessment – Geriatric (SCAG)*Journal of the American Geriatrics Society, 1974
- An Ergot Alkaloid Preparation (Hydergine) versus Papaverine in Treating Common Complaints of the Aged: Double‐Blind StudyJournal of the American Geriatrics Society, 1973
- An Ergot Alkaloid Preparation (Hydergine) Versus Placebo for Treatment of Symptoms of Cerebrovascular Insufficiency: Double‐Blind StudyJournal of the American Geriatrics Society, 1972
- An Ergot Alkaloid Preparation (Hydergine) in Geriatric TherapyJournal of the American Geriatrics Society, 1972
- AN ERGOT PREPARATION (HYDERGINE) IN THE TREATMENT OF CEREBROVASCULAR DISORDERS IN THE GERIATRIC PATIENT: DOUBLE‐BLIND STUDYJournal of the American Geriatrics Society, 1971
- Regional cerebral blood flow in senile and presenile dementiaNeurology, 1970
- Some Problems of Clinical Trials in Elderly PeopleGerontologia Clinica, 1961